![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » COVID-19 Blood Clot Risks Much Higher for Nonvaccinated Patients, Oxford Says
COVID-19 Blood Clot Risks Much Higher for Nonvaccinated Patients, Oxford Says
![COVID-19](https://www.fdanews.com/ext/resources/test/Drug-Images4/COVID-19-image.gif?t=1615503643&width=430)
Oxford University researchers have found that the risks of rare blood clots in the brain are significantly higher for COVID-19 patients than for vaccinated individuals.
The risk of cerebral venous thrombosis following COVID-19 infection is approximately “100 times greater than normal, several times higher than it is post-vaccination or following influenza,” the Oxford researchers found in a study of data from more than 500,000 COVID-19 patients.
The study evaluated real-world data on the AstraZeneca/Oxford vaccine, which has been linked to very rare but life-threatening blood clots, as well as the Pfizer/BioNTech and Moderna vaccines.
Upcoming Events
-
18Jul
-
21Oct